New, Low-Cost, Anti-Malaria Drug

Malaria has been, and continues to be a huge problem for many Africans. Around 3 million people per year die from the disease, most of those people are from Africa. Even worse, about 1 million of those deaths are African children. To try and help solve this problem, (or at least subside it), Europe's largest pharmaceutical company, Sanofi-Aventis and a non-profit organization, Drugs for Neglected Diseases Initiative (DNDI) have come together to create and distribute a low-cost drug to fight malaria. The drug contains two medications, therefore to help increase the likelihood of killing the parasite. Set at a low-cost most Africans will be able to purchase the drug. Why not make it free? Many Africans say that making it free makes them suspicious of the drugs intent, and putting a price on it that they can afford will be more popular with the population. Malaria is such a large problem, but has been solved by an easy-fix, a cheap drug that contains two medications instead of one. Getting Africa back on track is going to take a lot more than just selling drugs at a low cost, but at the same time helping the smaller issues and leaving the larger ones to Africa, such as civil war and corruption will help get their population strong enough to fight their own battles and win.